Allianz Asset Management’s BeOne Medicines Ltd ONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-700
Closed -$213K 2126
2025
Q4
$213K Sell
700
-2,700
-79% -$884K ﹤0.01% 1930
2025
Q3
$1.16M Buy
3,400
+100
+3% +$30.4K ﹤0.01% 1685
2025
Q2
$799K Buy
3,300
+900
+38% +$221K ﹤0.01% 1723
2025
Q1
$653K Buy
2,400
+400
+20% +$93.5K ﹤0.01% 1798
2024
Q4
$369K Buy
2,000
+1,000
+100% +$204K ﹤0.01% 1951
2024
Q3
$225K Buy
+1,000
New +$180K ﹤0.01% 2056
2021
Q4
Sell
-7,817
Closed -$2.84M 2721
2021
Q3
$2.84M Sell
7,817
-5,738
-42% -$1.88M ﹤0.01% 1505
2021
Q2
$4.65M Buy
13,555
+9,985
+280% +$3.31M ﹤0.01% 1152
2021
Q1
$1.24M Buy
+3,570
New +$1.18M ﹤0.01% 1569
2020
Q1
Sell
-5,685
Closed -$942K 2776
2019
Q4
$942K Sell
5,685
-14,150
-71% -$2.35M ﹤0.01% 2227
2019
Q3
$2.42M Buy
19,835
+15,475
+355% +$2.06M ﹤0.01% 1754
2019
Q2
$540K Sell
4,360
-27,072
-86% -$3.44M ﹤0.01% 2320
2019
Q1
$4.15M Sell
31,432
-28,628
-48% -$3.86M ﹤0.01% 1543
2018
Q4
$8.37M Buy
60,060
+20,625
+52% +$2.74M 0.01% 1200
2018
Q3
$6.79M Buy
39,435
+9,800
+33% +$1.65M 0.01% 1423
2018
Q2
$4.56M Buy
29,635
+80
+0.3% +$14.3K ﹤0.01% 1567
2018
Q1
$4.96M Sell
29,555
-4,525
-13% -$613K ﹤0.01% 1542
2017
Q4
$3.33M Buy
+34,080
New +$3.12M ﹤0.01% 1803

Other funds holding ONC

Allianz Asset Management's ONC Position: Q1 2026 in Review

Allianz Asset Management sold out of BeOne Medicines Ltd (ONC) in Q1 2026, closing a stake of 700 shares — an estimated $213K sold.

Allianz Asset Management first reported a position in ONC in Q4 2017 and held it in 18 quarters. The position peaked at $8.37M in Q4 2018. 282 funds tracked by Wall St. Rank hold ONC as of Q1 2026.

  • Allianz Asset Management reported no remaining BeOne Medicines Ltd position as of Q1 2026 after selling out during the quarter.
  • Allianz Asset Management sold 700 BeOne Medicines Ltd shares in Q1 2026, an estimated $213K.
  • Allianz Asset Management first reported a position in BeOne Medicines Ltd in Q4 2017 and held it in 18 quarters.
  • Allianz Asset Management's BeOne Medicines Ltd position peaked at $8.37M in Q4 2018.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2026.

Based on Allianz Asset Management's 13F filing for Q1 2026, filed 11 May 2026.